Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

BIIB Biogen Inc

148,82

-1,93 (-1,28%)

11 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Biogen (NASDAQ:BIIB)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Biogen Charts.

Biogen (NASDAQ:BIIB)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Biogen Charts.

News Biogen Inc

Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership
Freitag 10 Januar 2025 (1 Tag vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Dienstag 7 Januar 2025 (5 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 9 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 9 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities
Montag 9 Dezember 2024 (1 Monat vor) • Edgar (US Regulatory)

"LEQEMBI®" (Lecanemab) Approved for the Treatment of Early Alzheimer's Disease in Mexico
Donnerstag 5 Dezember 2024 (1 Monat vor) • PR Newswire (US)

"LEQEMBI®" (Lecanemab) for the Treatment of Alzheimer's Disease Launched in South Korea
Donnerstag 28 November 2024 (1 Monat vor) • PR Newswire (US)

Dapirolizumab Pegol Phase 3 Data Presented at the American College of Rheumatology Shows Significant Reduction in Systemic Lupus Erythematosus Disease Activity
Dienstag 19 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer's Disease
Donnerstag 14 November 2024 (2 Monate vor) • PR Newswire (US)

Eisai Receives Positive Opinion from the CHMP in the European Union for Lecanemab in Early Alzheimer’s Disease
Donnerstag 14 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 4 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Biogen Inc News-Artikel

Financial Select Sector

Deutsche Telekom (QX)

JP Morgan Chase

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen